Antoine Yver - EVP & Chairman Development, Centessa Pharmaceuticals Plc

As of June 21, 2022


What is Antoine Yver's Net Worth?

The current estimated net worth of Centessa Pharmaceuticals Plc's EVP & Chairman Development, Antoine Yver, is estimated to be about $3.33M . Antoine Yver owns about 739,697 units of Centessa Pharmaceuticals Plc common stock. In the last year at Centessa Pharmaceuticals Plc, Antoine Yver has sold an estimated value of $482.77K worth.

What is Antoine Yver's Past Insider Trading?

Antoine Yver's largest sale order was 85,000 units , worth over $439.73K on May 19, 2022. In total, Antoine Yver has made about 4 transactions over a year of their time at Centessa Pharmaceuticals Plc. Antoine Yver usually trades in June, with the busiest year in 2022. The most recent transaction was a sale order of 9,200 units , worth over $43.04K on June 21, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Antoine Yver's' Mailing Address?

  • Mailing address is C/o Centessa Pharmaceuticals Plc D. Hodgkin Bldg, Babraham Rsrch Campus Cambridge X0 CB22 3FH United Kingdom

What are Centessa Pharmaceuticals Plc's Past Insider Trades?

Centessa Pharmaceuticals Plc's most recent insider trade came on June 21, 2022 by Antoine Yver who sold 9,200 units worth $43.04K . In the last year, insiders at Centessa Pharmaceuticals Plc have sold an estimated value of $482.77K and bought an estimated value of $75.08M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Francesco Rubertis de, Director,  Medicxi Ventures Management Jersey Ltd,  and Antoine Yver, EVP & Chairman Development .

Centessa Pharmaceuticals plc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1